Introduction
Every great collaboration starts with a shared vision. For us at ImmunoIVD, that vision is clear: enabling early detection to ensure life-saving interventions for every newborn.
Recently, we had the privilege of immersing ourselves in Malaysia’s newborn screening ecosystem alongside Arcadia Life Sciences — a leading biotechnology company specializing in biomarker discovery.
From insightful discussions to hands-on lab visits, it was about sharing knowledge and experiences, learning from each other, and building bridges that save lives.
This collaboration marks an important step in strengthening newborn screening programs — with more shared progress ahead.
